Entreprise · 03/06/20081 min de lecture
Determination of Regulatory Review Period for Purposes of Patent Extension; TYZEKA; Correction
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of May 15, 2008 (73 FR 28119), announcing FDA's determination of the regulatory review period for TYZEKA. The document published with an incorrect docket number. This document corrects that error.